IL1B and Renal amyloidosis: Importantly, IL-1 inhibiting strategy demonstrated high efficiency in achieving complete disease remission, as well as improvement or stabilization of kidney function in colchicine-resistant FMF patients with renal amyloidosis (114, 115, 118).